Moderna details coronavirus vaccine pricing as orders roll in
Small COVID-19 vaccine doses could cost $32-$37.
Small COVID-19 vaccine doses could cost $32-$37.
Volunteers from Phoenix to participate in COVID-19 vaccine trials
Phoenix is playing a vital role in helping researchers and doctors find a vaccine for the coronavirus.
Phoenix is playing a vital role in helping researchers and doctors find a vaccine for the coronavirus.
Virus vaccine put to final test in thousands of volunteers
The world's biggest COVID-19 vaccine test got underway Monday with the first of 30,000 planned volunteers.
The world's biggest COVID-19 vaccine test got underway Monday with the first of 30,000 planned volunteers.
4 Arizona medical institutions listed as study locations for new COVID-19 vaccine
Some Arizona medical institutions were listed as study locations for a clinical trial on a vaccine designed to protect humans against the coronavirus that causes COVID-19.
Some Arizona medical institutions were listed as study locations for a clinical trial on a vaccine designed to protect humans against the coronavirus that causes COVID-19.
First COVID-19 vaccine tested in US produced antibodies in all patients during trial
The experimental vaccine, developed by Fauci’s colleagues at the National Institutes of Health and Moderna Inc., will start its most important step around July 27: A 30,000-person study to prove if the shots really are strong enough to protect against the coronavirus.
The experimental vaccine, developed by Fauci’s colleagues at the National Institutes of Health and Moderna Inc., will start its most important step around July 27: A 30,000-person study to prove if the shots really are strong enough to protect against the coronavirus.
Who would be the first to get a COVID-19 vaccine?
Who would be the first to get a COVID-19 vaccine? Probably people in the country where the first effective vaccine is developed.
Who would be the first to get a COVID-19 vaccine? Probably people in the country where the first effective vaccine is developed.
Moderna finds neutralizing antibodies in Phase 1 trial of COVID-19 vaccine
Moderna, a pharmaceutical company racing to develop a vaccine for COVID-19, found promising results in Phase 1 of its drug trial.
Moderna, a pharmaceutical company racing to develop a vaccine for COVID-19, found promising results in Phase 1 of its drug trial.